Clinical Trial Details

Study of Safety and Efficacy of RGT-61159 in Adults with Relapsed/?Refractory Adenoid Cystic Carcinoma (ACC) or Colorectal Carcinoma (CRC)

Complete Title: A Phase 1a/1b, First-in-human, Multicenter Study to Assess the Efficacy and Safety of RGT-61159 for Treatment of Patients with Relapsed/Refractory Adenoid Cystic Carcinoma (ACC) or Colorectal Carcinoma (CRC)
Trial Phase: I
Investigator: Cristina Rodriguez

Phase 1 study to evaluate safety, tolerability and anti-tumor activity of RGT-61159 in patients with ACC or CRC

Keywords:
  • Neoplasms, Cystic, Mucinous, and Serous; Colorectal Neoplasms
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.
Checklist icon

Join a Clinical Trial

Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each clinical trial.

Contact Us

If you are seeking to schedule an appointment, we are here to help. You can either call us or fill out our online appointment request form.